Next Generation Pharma Solutions.
NextPharma Technologies, headquartered in the UK and founded in 2000, is a world class outsourcing partner to the pharmaceutical and biotechnology industry.
We offer a full range of services from early phase product development, through clinical trial supplies to high volume commercial manufacturing. NextPharma is a world leader in specialist product manufacturing including penicillins, cephalosporins, sterile cytotoxics, non-cytotoxics and hormones. Additionally, we also manufacture eye and ear drops, tablets and capsules, oral and topical liquids, semi-solids and pellet technologies. Our sterile development and production capabilities offer a full range of drug delivery technologies including pre-filled syringes, vials and ampoules.
Company News
New press release
NextPharma Technologies Announces First GMP Manufacture at its Sterile Product Development Center in Belgium
Click here to get our latest press release.
NextPharma Technologies US Subsidiary Announces Outsourcing Agreement With Advantar Laboratories Inc.
Click here to get this press release.
NextPharma Technologies Expands Temperature Controlled Storage Facilities in Stockerau, Austria
Click here to get this press release.
SPDC News
NextPharma's Product Development Services division is pleased to announce that its' Sterile Product Development Centre (SPDC) in Braine-l'Alleud, Belgium opened officially on 1st October 2008.
Click here to read more...
NextPharma Corporate Brochure
Click here to download NextPharma's latest corporate brochure (PDF file).
Customer Newsletter Archive
Get more details about NextPharma's business and services by entering our newsletter archive.
Enter here...
You would like to receive our monthly e-communication to get information on NextPharma's expanding capabilities and services?
Subscribe now!
News in Brief
BIO2009
Congratulations to Q.F.B. Araceli Olguin Jimenez, the winner of our drawing for an IPod Touch at BIO2009.
NextPharma Technologies Opens New Clinical Trials Services Facility at its Göttingen Site in Germany
NextPharma Technologies Receives Successful FDA Inspection at its Waltrop site in Germany
Bill Wedlake, CEO, NextPharma Technologies, commented: ‘This positive endorsement of our Waltrop site is another major step for NextPharma in its objective to be the leading provider of World Class, quality pharmaceutical product development and contract manufacturing services to the global pharmaceutical and biotechnology market’.


